Trial Profile
A Multicenter, Open-Label, Phase II Trial of Adjuvant Taxotere in Patients At High Risk of Relapse Following Prostatectomy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jun 2011
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors Aventis Pharmaceuticals; Sanofi
- 07 Jun 2011 Actual end date (Jan 2007) added as reported by ClinicalTrials.gov.
- 07 Jun 2011 Actual end date (Jan 2007) added as reported by ClinicalTrials.gov.
- 10 Jul 2007 Status change from in progress to completed.